pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
PUBLIC COMPANY
save

$IARTINTEGRA LIFESCIENCES HOLDINGS CORP

$IART18.24+4.95%
Princeton, NJ, USupdated 11h ago

Integra LifeSciences Holdings Corporation is a global medical device manufacturing company headquartered in Princeton, New Jersey. Founded in 1989, the company manufactures products for skin regeneration, neurosurgery, reconstructive and general surgery. Integra artificial skin became the first commercially reproducible skin tissue used to treat severe burns and other skin wounds.

Website ↗SEC EDGAR ↗Yahoo Finance ↗
community read0 votes
pipeline
0
marketed
0
phase 3
0
catalysts ytd
9
approvals ytd
0
recalls ytd
3

Pipeline(0)

no pipeline products on record

📅 Upcoming

Oct 29, 2026
earnings
$IART18.24+4.95%
in 3mo
INTEGRA LIFESCIENCES HOLDINGS CORP earnings
INTEGRA LIFESCIENCES HOLDINGS CORP
→

🕒 Recent(90d)

earnings (1)
Jul 30, 2026
earnings
$IART18.24+4.95%
15d ago
INTEGRA LIFESCIENCES HOLDINGS CORP earnings
INTEGRA LIFESCIENCES HOLDINGS CORP
→
view all catalysts →

Active trials

  • N/AA Modified Platform Trial of Multiple CAMPs for the Management of Diabetic Foot Ulcers and Venous Leg Ulcersenrolling by invitationn=350
  • N/AMicroMatrix® Flex in Tunneling Woundscompletedn=25
  • —Post Market Clinical Follow-up of CODMAN CERTAS Programmable Valveactive not recruitingn=160
  • —The MIRROR Registry: Minimally Invasive IntRaceRebral HemORrhage Evacuationrecruitingn=500
  • —External Ventricular Drainage Post-Market Clinical Follow-up Registrycompletedn=120
  • —Tissue Quality of Integra vs. BTM Treated Burnswithdrawn
  • —AERA Pediatrics Registryrecruitingn=300
  • N/AThe Purpose of This Study is to Determine Whether CerebroFlo™ EVD Catheter is Effective During the Treatment of Intraventricular Hemorrhage (IVH)completedn=105
more trials →

Insider activity

source: SEC Form 4
routine RSU / option mechanics (6)
  • Mar 11, 26tax coverDAVIS ROBERT T. JR. · EVP & President, TT8,487 sh
  • Mar 11, 26tax coverKnight Lea Daniels · EVP & Chief Financial Officer8,089 sh
  • Mar 11, 26tax coverMcBreen Michael J. · EVP & President, CSS7,247 sh
  • Mar 11, 26tax coverVeillon-Berteloot Chantal · EVP & CHRO5,420 sh
  • Mar 11, 26tax coverSingh Harvinder · EVP & PRESIDENT, INTERNATIONAL5,190 sh
  • Mar 11, 26tax coverSingh Harvinder · EVP & PRESIDENT, INTERNATIONAL861 sh
🐶 Hiring Signal
next earnings Oct 29, 2026
No open roles indexed yet — view INTEGRA LIFESCIENCES HOLDINGS CORP jobs →

News

no news has mentioned this company yet
identifiers
ticker
$IART
SEC CIK
0000917520
country
US
source
sec_tickers
mentioned in
0news items
entity-linker matched
Data sources
SEC EDGAR · openFDA
last refreshed 24m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?